发明名称 Test for predicting neutralization of asparaginase activity
摘要 Method of in vitro measurement of the presence of factors that are able to neutralize asparaginase activity in a sample of blood, plasma, serum or derived medium that may contain asparaginase neutralizing factors, obtained from a patient, comprising mixing of said sample with asparaginase, incubation of said mixture, then measurement of the residual asparaginase activity in the mixture and determination or quantification of the presence of said neutralizing factors. Method for predicting the efficacy of a treatment with asparaginase.
申请公布号 US9580739(B2) 申请公布日期 2017.02.28
申请号 US201414489556 申请日期 2014.09.18
申请人 ERYTECH PHARMA 发明人 Godfrin Yann
分类号 C12Q1/34;A61K38/50 主分类号 C12Q1/34
代理机构 Stites & Harbison, PLLC. 代理人 Weyer, Esq. Stephen J.;Stites & Harbison, PLLC.
主权项 1. A method of treatment of an asparaginase-sensitive pathology in a patient, said methods comprising: (a) obtaining a sample of blood, plasma, or serum from a patient; (b) incubating said sample with a known amount of asparaginase for a period of time sufficient to produce antibody-asparaginase immune complexes; (c) removing from the incubated sample any antibody-asparaginase immune complexes formed during incubation step (b) and recovering a sample free of antibody-asparaginase immune complexes; (d) incubating the sample obtained at step (c) with asparagine; (e) determining a residual asparaginase activity or the amount of asparaginase residual activity in the resultant mixture of step (d); and (f) treating said patient by means of the asparaginase and/or by means of another form of asparaginase.
地址 Lyons FR
您可能感兴趣的专利